Global Cell Therapy Market Trends, Drivers and Restraints During the Forecast Period, 2017-2025 - ResearchAndMarkets.com

DUBLIN--()--The "Cell Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

The report on the global cell therapy market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global cell therapy market to grow with a healthy CAGR over the forecast period from 2019-2025.

The report on cell therapy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cell therapy market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cell therapy market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Increasing incidences of cancer across the globe
  • Growing aging patient population
  • Rise in cell therapy transplantations

2) Restraints

  • The high cost of transplantation treatment
  • Stringent regulatory policies

3) Opportunities

  • Automation in cell therapy
What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the cell therapy market.

2. Complete coverage of all the segments in the cell therapy market to analyze the trends, developments in the global market and forecast of market size up to 2025.

3. Comprehensive analysis of the companies operating in the global cell therapy market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered:

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Cell Therapy Market Highlights

2.2. Cell Therapy Market Projection

2.3. Cell Therapy Market Regional Highlights

3. Global Cell Therapy Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Cell Type

3.4.2. Growth Matrix Analysis by Therapy Type

3.4.3. Growth Matrix Analysis by Application

3.4.4. Growth Matrix Analysis by End-users

3.4.5. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Cell Therapy Market

4. Cell Therapy Market Macro Indicator Analysis

5. Global Cell Therapy Market by Cell Type

5.1. Stem Cell

5.2. Differentiated Cell

6. Global Cell Therapy Market by Therapy Type

6.1. Allogenic Therapies

6.2. Autologous Therapies

7. Global Cell Therapy Market by Application

7.1. Autoimmune Diseases

7.2. Oncology

7.3. Dermatology

7.4. Muscoskeletal Therapies

7.5. Other Applications

8. Global Cell Therapy Market by End-users

8.1. Hospitals and Clinics

8.2. Biotechnology and Pharmaceutical Companies

8.3. Research Institutes

9. Global Cell Therapy Market by Region 2019-2025

9.1. North America

9.1.1. North America Cell Therapy Market by Cell Type

9.1.2. North America Cell Therapy Market by Therapy Type

9.1.3. North America Cell Therapy Market by Application

9.1.4. North America Cell Therapy Market by End-users

9.1.5. North America Cell Therapy Market by Country

9.2. Europe

9.3. Asia-Pacific

9.4. RoW

10. Company Profiles and Competitive Landscape

10.1. Competitive Landscape in the Global Cell Therapy Market

10.2. Companies Profiled

10.2.1. NuVasive, Inc

10.2.2. Kolon TissueGene, Inc.

10.2.3. JCR Pharmaceuticals Co., Ltd.

10.2.4. Osiris Therapeutics, Inc.

10.2.5. Stemedica Cell Technologies, Inc.

10.2.6. MEDIPOST

10.2.7. Stemedica Cell Technologies, Inc.

10.2.8. Celgene Corporation

10.2.9. ANTEROGEN.CO., LTD

10.2.10. Vericel Corporation

For more information about this report visit https://www.researchandmarkets.com/r/vjtjzz

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics